Lu 177 is basically everywhere!!
BNT316 / ONC-392 phase 1/2 trial in c... - Advanced Prostate...
BNT316 / ONC-392 phase 1/2 trial in combination with Lu177
Written by
Maxone73
To view profiles and participate in discussions please or .
2 Replies
•
Is this available to someone who is currently on Pluvicto alone? I got lost in the article and did not look for any studies on clinicaltrials.gov
You could be, it’s not mentioned in the criteria
Not what you're looking for?
You may also like...
Second generation selective PARP inhibitor: PETRANHA: Phase 1/2 study of AZD5305 + novel hormonal agents in patients mPCa
...as I reported, one of the patients on the trial (with ATM mutation) had a 100% remission......
Phase 1-2 study for niclosamide-based drug:
…thought they made cars… 😜
“Hyundai’s formulation claims to have a high enough drug concentration...
Clarity Update: Complete response in first patient ever treated with 2 doses of Cu-67 SAR-bisPSMA at 8GBq
Highlights
A complete response, based on Response Evaluation Criteria In Solid Tumours (RECIST...
copper chelation is not something from the past: phase 2 trial gives hope!
in heavily pre treated mCRPC
Although the last participants in cohort 3 only completed dosing in...
Phase 1 trial participation Nurix NX-1607
I have not been on any treatment since I stopped Docetaxel chemo last year except Prostap...
Related Posts
- Having a bad day, let's cheer up with a new treatment in phase 1/2 212Pb-ADVC001, a Targeted Alpha Therapy
RECENTLY DIAGNOSED STAGE4 ADVANCED PCa WITH 2 METS IN BONES & 3 LYMPH NODES - Prognosis 3 - 5 yrs. How to cope and is 3 to 5 years realistic
PSMAddition Phase 1/2 Results?
Addition of Metastasis-Directed Therapy to Intermittent Hormone Therapy for Oligometastatic PC. The EXTEND Phase 2 Randomized Clinical Trial
Phase 1 study SBRT for bone metastases in oligometastatic patients. So far, "few toxicity events and high local control rate"
